INTRODUCTION
Paracetamol or acetaminophen is a widely used over-the-counter analgesic and antipyretic drug (Fiebich et al., 2000) . Generally it is used to treat headache, other minor aches and pains and also in cold and flu remedies. It could also be used in the management of more severe pain like pain in cancer in combination with other drugs (Kalakuntla et al., 2010) . At present, beside paracetamol, a new paracetamol/caffeine formulation is designed to deliver faster dissolving and more quickly absorbed drug product (Liu et al., 2011) . Along with paracetamol, the combination product is also available and well established medicine in Bangladesh due to patients' acceptability (Islam et al., 2012) .
Caffeine is a central nervous system stimulant, naturally produced in the leaves and seeds of many plants. It increases alertness, boosts up energy and elevates mood of most of the peoples (Islam et al., 2012) . It is a common adjuvant for analgesic drugs such as paracetamol and acetylsalicylic acid (Smith, 1998; Sawynok and Yaksh, 1993; Lipton et al., 1998; Ward et al., 1991; Liu et al., 2011) . Moreover, solubility of paracetamol is increased in the presence of caffeine (Okore and Osuji, 2001) . Caffeine also accelerates the absorption of paracetamol and therefore provides enhanced and prolonged analgesic activity (Renner et al., 2007) .
The clinical effectiveness exerted by tablet formulation depends on at least two factors such as, the drug must be present in the labeled amount and its availability to the body (Jabeen et al., 2006) . The main objective of an oral tablet is to deliver the drug to the human body at certain and defined amount through the gastro-intestinal system for producing therapeutic effect (Islam et al., 2011) . The formulation of the drug product can have a significant effect on the quality parameters such as weight variation, hardness, friability, disintegration time, dissolution profile etc. This also includes the physiochemical properties of the active ingredients and excipients as well as the procedures used in the manufacturing process (Ofori-Kwakye et al., 2010; Kalakuntla et al., 2010) .
Moreover, quality control parameters also or physical properties of tablet are useful tools for maintaining consistency in batch-to-batch manufacturing and it should be performed for every drug product. All of these parameters are closely related to each other and have effect on drug absorption, bioavailability etc. (Awofisayo et al., 2010; Jain et al., 2012) . The aim of the study was to evaluate the comparative quality control parameters between the tablets of two formulations because standard quality parameters are essential for better quality of medicine.
MATERIALS AND METHODS

Study design
Comparative in-vitro quality control parameters between the commercially available tablet brands of paracetamol and paracetamol/caffeine combination in Bangladesh were studied through the evaluation of weight variation, hardness, friability, disintegration time and dissolution profile. The study was done by performing various test procedures associated to assess the quality of tablets.
Sample collection
To perform the study both paracetamol and paracetamol/caffeine tablets of five different top level manufacturers were purchased from the drug store of Noakhali, Bangladesh. All the tablet brands of paracetamol were labeled to contain 500 mg of paracetamol per tablet and the paracetamol/caffeine brands were labeled to contain 500 mg of paracetamol and 65 mg of caffeine per tablet. The labeled shelf life of all of the tablets was three years from the date of manufacturing and was taken for the evaluation before two years of the labeled expiry date.
Sample identification
After purchasing, tablets of all the brands were coded as A1, B1, C1, D1 and E1 for paracetamol tablets of five different manufacturers and A2, B2, C2, D2 and E2 for paracetamol/caffeine tablets of the same five manufacturers. Finally the coded samples were separated as a pair of paracetamol and paracetamol/caffeine of the same manufacturer and taken for evaluation.
Procedure of evaluation
Various analytical methods and tests are important for the development and manufacture of pharmaceutical formulations (Nijhu et al., 2011) . For the evaluation, following quality control tests were performed for all the tablet brands of two formulations in the study.
Weight variation test
The variation of the weight of individual tablet is a valid indication of the corresponding variation in the drug content (Rawlian, 1977) . Controlling tablet weights within a tight range will contribute to better tablet hardness and friability (Tousey, 2011).The acceptable limit for the deviation of weight for tablets having average weight of 250 mg or more should not exceed 5% (British Pharmacopoeia, 2005) . Ten tablets were selected from each of the brand and weighed individually using electronic balance (Adventurer, OHAUS, USA, Model: AR2140). Their average weights were calculated. For all tablet brands following mathematical equation was used for weight variation (Kalakuntla et al., 2010) : 
Hardness test
Hardness indicates the capability of a tablet to withstand mechanical shocks during handling in manufacturing, packaging and shipping (Banker and Anderson, 2009 ). The acceptable range of hardness or crushing strength of tablet is 4 to 7 kgf (kilogram of force) (Musa et al., 2011) . During the study, hardness of all tablets was determined using Tablet Breaking Force Tester, USP-1217 (Electrolab: EH-01P). For both of the formulations, five tablets of each brand were taken and hardness of the tablets was determined.
MATERIALS AND METHODS
Friability test
Friability test is essential to evaluate the ability of a tablet to withstand abrasion in packing , handling and transporting. In the study, it was determined using Electrolab EF-2 Friabilator (USP). The value of friability was expressed in percentage (%). Ten tablets for each brand were initially weighed and transferred into friabilator. The friabilator was operated at 25 rpm for 4 minutes (up to 100 revolutions). The tablets were weighed again and the percent (%) friability was then calculated by using following formula (Kalakuntla et al., 2010) . Generally the considerable range of weight loss of conventional compressed tablet is less than 0.5 to 1% (Banker and Anderson, 2009 
Disintegration test
Disintegration is the break down process of tablet into smaller particles and is the first step towards dissolution. The standard disintegration time for USP uncoated tablet must be as low as 5 minutes but majority of the tablets have a maximum disintegration time of 30 minutes (Banker and Anderson, 2009 ).The method specified in the USP/NF (1980) was used (Disintegration Tester-USP, Electrolab: ED-2L). The volume of disintegration medium used was 100ml of 0.1N HCl and the temperature was maintained at 37±1°C throughout the experiment for each tablet of all the brands. Six tablets of each brand were selected and placed in each of the cylindrical tubes of the basket and the disc was used. The time taken to break each tablet into small particles and pass out through the mesh was recorded. Mean disintegration time was calculated for each of the brands (Gangwar et al., 2010) .
Dissolution test
Generally dissolution test is carried out to determine drug release pattern during a specific period of time (Kishore et al., 2011) . Dissolution test for each of the tablet brands was performed using Dissolution Tester -USP (Electrolab, TDT-08L Plus). 900 ml of phosphate buffer, pH 7.4 was used as dissolution medium (Kishore et al., 2011) . The process was done at a speed of 50 rpm by maintaining temperature at 37±1ºC in each test. Samples were withdrawn as 5 ml at a regular time intervals of 10 minutes which was predetermined and same procedure was continued up to 30 minutes by replacing equal amount of fresh dissolution medium (phosphate buffer, pH 7.4). The filtered samples were suitably diluted and analyzed using UV Spectrophotometer (SHIMADZU UV Spectrophotometer: UV-1800-240V) at 257nm for paracetamol. By measuring the absorbance, the percentage (%) of drug release was calculated (Kishore et al., 2011; Kalakuntla et al., 2010) .
Data processing and analysis
After the completion of all test procedures data for all the individual tablets were recorded and separated on a different sheets according to the manufacturer. Finally data were analyzed by using the above mentioned mathematical formula and MS-Excel®, 2007.
RESULTS AND DISCUSSION
During the study, at first the weight variation which is the key to controlling crushing strength and friability of tablet was assessed (Tousey, 2011). The unofficial test stated that all the samples of paracetamol coded A1, B1, C1, D1, E1 and samples of paracetamol/caffeine coded A2, B2, C2, D2, E2 have passed the weight variation uniformity test as specified in the British Pharmacopoeia (not exceed 5% deviation) (British Pharmacopoeia, 2005) . Weight variation uniformity between two groups of tablets was almost same though caffeine was added as adjuvant in one group.
Hardness is the second most important physical feature for assessing tablet (Tousey, 2011). In the study, it was found that A1, B1, C1 and E1 brands of paracetamol group passed the test of tablet crushing strength or hardness. These brands had acceptable crushing strength of between 4.31 kgf to 6.98 kgf except sample D1 which was the hardest of all the paracetamol tablet brands with a hardness of 9.17 kgf, indicated that it was above the limit range of between 4 to 7 kgf stated (Musa et al., 2011) . On the other hand, the paracetamol/caffeine tablet brands had a crushing strength of between 5.99 kgf to 11.55 kgf. Only A2 and B2 brands showed satisfactory crushing strength but the value of rest of the three brands C2, D2 and E2 were above the range. The study revealed that all the brands of paracetamol/caffeine combination were harder than the brands of paracetamol. It might be the cause of
increasing tablet weight for combination formulation (Tousey, 2004) .
In the friability test, all brands showed impressive friability values. The friability values for paracetamol tablet brands were ranged from 0.21 to 0.64% whereas the paracetamol/caffeine tablet brands showed 0.09 to 0.34% of friability. In all formulations the percent (%) friability was less than 1% which ensures that all the tablets of each brand of both formulations were mechanically stable (Kalakuntla et al., 2010) .
The disintegration time of all tablet brands of paracetamol A1, B1, C1, D1 and E1 was satisfactory as uncoated USP tablets have disintegration time standards as low as 5 minutes (Banker and Anderson, 2009 ). Whereas tablets of paracetamol/caffeine A2, B2, C2, D2 and E2 showed higher disintegration time though they also meet the maximum limit of 30 minutes (Banker and Anderson, 2009 ).The overall disintegration time for paracetamol tablet brands was in the ranged from 24 seconds to 4 minutes 52 seconds while paracetamol/caffeine tablet brands ranged from 6 minutes 33 seconds to 17 minutes 43 seconds. So the disintegration time for paracetamol/caffeine tablet brands is much higher than the paracetamol tablet brands. The results obtained in the study showed that the hardness or breaking strength of the tablets directly relates with the disintegration time, i.e. more hardness of paracetamol/caffeine tablets increased their disintegration time than the tablets of paracetamol (Ahmed et al., 1998) . Results of weight variation, hardness, friability and disintegration tests are shown in Table 1 .
Dissolution was another studied important quality control parameters directly related to the absorption and bioavailability of drug (Pabla et al., 2009) . The study revealed that at different time intervals drug release rate was better in paracetamol/caffeine tablet brands comparing with the paracetamol alone. After 10 minutes, the release rate of tablet brands of paracetamol was 38.92 to 51.19% whereas release rate of paracetamol/caffeine tablets was 43.97 to 57.11% which showed that initial release rate of paracetamol/caffeine combination was more than paracetamol alone and this also continued after 20 minutes. Finally after 30 minutes, 99-100% drug release was observed in A1 and B1 for paracetamol brands and A2, B2, C2 and E2 for paracetamol/caffeine brands. All other brands of both groups also showed more than 90 % drug release after 30 minutes. The better dissolution profile of paracetamol/caffeine might be the impact of caffeine, as the solubility of paracetamol is accelerated by caffeine (Okore and Osuji, 2001) . Outcome of the test has been shown in Table 2 and Figure 1. Paracetamol is a well established and proven analgesic and antipyretic drug. The current pharma market of Bangladesh is flooded with various combination preparations. With other combination formulation, paracetamol/caffeine is also now widely used for the management of different pain in the country. Therapeutic response of any formulation depends on its quality parameters. From the study it was identified that weight variation and friability test of both paracetamol and paracetamol/caffeine tablet brands complied the specification. Variation was obtained in hardness, disintegration time and dissolution profile during the test procedure. Paracetamol/caffeine tablets were found harder than tablets having only paracetamol and the combination brands also increased the time of disintegration. It should be strictly considered that an ideal tablet will have sufficient hardness to maintain its mechanical stability but not more. Because harder tablet can delay disintegration time or alter dissolution profile. On the other hand, paracetamol/caffeine tablet brands showed better disintegration profile than the single paracetamol brands. At every interval drug release rate was more in paracetamol/caffeine tablets than paracetamol alone. This might be resulted by the presence of caffeine in the formulation as it increased the solubility of paracetamol followed by dissolution profile. Finally, as quality control parameters are related to one another from initial step to pharmacological action of the drug, a high-quality tablet either single or in combination should meet all the standard quality parameter for getting its desired therapeutic response.
